ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1873–1884 of 2020 project topics
KAT6A Syndrome Gene Variant Characterization
Identifying and classifying KAT6A pathogenic variants causing speech delay, cardiac defects, and microcephaly for molecular diagnosis.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
Coffin-Siris Syndrome Gene Panel Testing
Developing BAF complex gene panels including ARID1B, SMARCA4, and SMARCB1 for Coffin-Siris syndrome molecular diagnosis.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
PCDH19-Related Epilepsy Digital Diagnostic SaaS Platform
A cloud-based software platform that automates PCDH19 gene variant detection and interpretation for early-onset febrile seizure diagnosis in pediatric populations. This platform reduces diagnostic time from weeks to days, enabling laboratories to process 10x more patient samples monthly and establish recurring subscription revenue from clinical diagnostics centers.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
ARX Gene Mutation Screening Microarray Commercial Kit
A targeted microarray product designed for rapid detection of ARX gene variants associated with infantile spasms and lissencephaly in newborn screening programs. This consumable-based offering generates predictable recurring revenue through hospital procurement channels while reducing diagnostic turnaround time to under 48 hours.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
CASK X-Linked Neurodevelopmental Disorder NGS Testing Service
A next-generation sequencing testing service that identifies CASK gene mutations responsible for X-linked intellectual disability and neurodevelopmental delay with 99.9% accuracy. This service captures high-margin testing fees from pediatric neurology clinics and genetic counseling centers while building proprietary variant databases for competitive advantage.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
SETBP1 Variant Interpretation Engine with Clinical Analytics Dashboard
An AI-powered software tool that interprets SETBP1 gene variants and predicts developmental and seizure phenotypes using machine learning trained on 50,000+ patient cases. This enterprise dashboard platform charges per-analysis fees while licensing proprietary phenotype prediction algorithms to pharmaceutical research organizations developing targeted therapies.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
SYNGAP1 Encephalopathy Risk Stratification Biomarker Panel
A multi-biomarker panel service that quantifies SYNGAP1 mutation severity and predicts therapy response likelihood in early infantile epileptic encephalopathy cases. This value-added diagnostic offering commands premium pricing from major medical centers and enables partnerships with neurodevelopmental pharmaceutical companies conducting patient stratification studies.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
GRIN2B Variant Database and Phenotype Matching Commercial API
A RESTful API platform providing real-time GRIN2B gene variant classification and patient phenotype matching against a proprietary database of 15,000+ sequenced cases. This B2B SaaS offering generates recurring API licensing revenue while enabling clinical decision support integration into existing EHR systems and genomics workflows.
Genetic Basis of Neurodevelopmental Syndromes Click to view more details →
CIDP Genetic Risk Factor Investigation
Investigating HLA alleles and genetic variants predisposing to chronic inflammatory demyelinating polyneuropathy for understanding disease pathogenesis.
Genetic Basis of Inflammatory Neuropathies Click to view more details →
Multifocal Motor Neuropathy Genetics Research
Studying genetic factors contributing to multifocal motor neuropathy susceptibility and anti-GM1 antibody production.
Genetic Basis of Inflammatory Neuropathies Click to view more details →
Hereditary Neuropathy with Liability PMP22 Testing
Detecting PMP22 17p11.2 deletions causing HNPP for distinguishing from inflammatory neuropathies in patients with episodic weakness.
Genetic Basis of Inflammatory Neuropathies Click to view more details →
Vasculitic Neuropathy Genetic Predisposition
Identifying genetic risk factors for systemic vasculitis-associated neuropathies including ANCA-associated vasculitis genetic contributors.
Genetic Basis of Inflammatory Neuropathies Click to view more details →